派博傳思國際中心

標(biāo)題: Titlebook: Concomitant Continuous Infusion Chemotherapy and Radiation; Marvin Rotman (Professor and Chairman, Dept. of Ra Textbook 1991 Springer-Verl [打印本頁]

作者: mobility    時間: 2025-3-21 19:18
書目名稱Concomitant Continuous Infusion Chemotherapy and Radiation影響因子(影響力)




書目名稱Concomitant Continuous Infusion Chemotherapy and Radiation影響因子(影響力)學(xué)科排名




書目名稱Concomitant Continuous Infusion Chemotherapy and Radiation網(wǎng)絡(luò)公開度




書目名稱Concomitant Continuous Infusion Chemotherapy and Radiation網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Concomitant Continuous Infusion Chemotherapy and Radiation被引頻次




書目名稱Concomitant Continuous Infusion Chemotherapy and Radiation被引頻次學(xué)科排名




書目名稱Concomitant Continuous Infusion Chemotherapy and Radiation年度引用




書目名稱Concomitant Continuous Infusion Chemotherapy and Radiation年度引用學(xué)科排名




書目名稱Concomitant Continuous Infusion Chemotherapy and Radiation讀者反饋




書目名稱Concomitant Continuous Infusion Chemotherapy and Radiation讀者反饋學(xué)科排名





作者: 祝賀    時間: 2025-3-21 21:27
Time-Specified Delivery of Chemotherapy by Implantable Programmable Pumps — Preliminary Data on 5-Fltotoxic therapy. The treatment goal for these metastatic tumors is palliation, not cure. As chemotherapy may not even prolong survival significantly, its application needs to be critically reviewed as to how it affects the patient’s quality of life.
作者: 名次后綴    時間: 2025-3-22 04:13
Glutathione, a Determinant of Response to Cancer Treatmentth the responsive tumor types and the much broader spectrum of malignancies in which chemotherapy usually plays at best a palliative role have allowed the establishment of a number of principles that may allow the rational design of curative treatment for most cancer.
作者: 臭了生氣    時間: 2025-3-22 04:52

作者: 表狀態(tài)    時間: 2025-3-22 11:09
https://doi.org/10.1007/3-7908-1705-8and poor quality of delivery, coupled with disappointing results and significant morbidity, caused surgeons to remain antagonistic. Once supervoltage irradiation became available, results improved and it was possible to treat patients to tumoricidal doses within normal tissue tolerance dose levels.
作者: 小蟲    時間: 2025-3-22 15:34
https://doi.org/10.1007/978-981-13-7685-6r, demonstrate a marked schedule dependency - i.e., at equivalent AUCs, a prolonged infusion will yield much greater tumor cell kill than a shorter infusion or bolus. Other anticancer drugs may exhibit a marked concentration dependency, such that the reverse is true.
作者: 小蟲    時間: 2025-3-22 18:51

作者: CODA    時間: 2025-3-23 00:00

作者: 最高點(diǎn)    時間: 2025-3-23 04:58

作者: chance    時間: 2025-3-23 09:01

作者: Induction    時間: 2025-3-23 12:56
Advances in the Technology of Continuous Infusiona large bore vein, a catheter with an entry site, and a mechanical device providing a constant flow. The technological advances, as well as their advantages over the traditional techniques, are reviewed below. The pitfalls and potential complications will also be briefly analyzed.
作者: 同義聯(lián)想法    時間: 2025-3-23 14:34

作者: Regurgitation    時間: 2025-3-23 20:07

作者: SLUMP    時間: 2025-3-23 23:57
0942-5373 ent of cancer. This comprehensive book on the subject includes, besides a discussion of its scientific basis, the most promising clinical data on the use of continuous infusion chemotherapy and radiation. Thus, it is an important update for clinical investigators involved in frontline research as we
作者: MOT    時間: 2025-3-24 03:42
Munich Studies on Innovation and Competitiontotoxic therapy. The treatment goal for these metastatic tumors is palliation, not cure. As chemotherapy may not even prolong survival significantly, its application needs to be critically reviewed as to how it affects the patient’s quality of life.
作者: tooth-decay    時間: 2025-3-24 08:07
https://doi.org/10.1007/978-3-031-26786-4th the responsive tumor types and the much broader spectrum of malignancies in which chemotherapy usually plays at best a palliative role have allowed the establishment of a number of principles that may allow the rational design of curative treatment for most cancer.
作者: 領(lǐng)袖氣質(zhì)    時間: 2025-3-24 14:04
Combination Chemotherapy by Infusion in Hematological Malignanciesse of infusional chemotherapy in multiple myeloma. Infusional therapy for the acute leukemias has been considered standard therapy for some time now and as such is regarded as beyond the limits of this review.
作者: APNEA    時間: 2025-3-24 18:13
Efficacy of 5-Fluorouracil by Continuous Infusion as a Radiopotentiator — Anal and Rectal Carcinomaand poor quality of delivery, coupled with disappointing results and significant morbidity, caused surgeons to remain antagonistic. Once supervoltage irradiation became available, results improved and it was possible to treat patients to tumoricidal doses within normal tissue tolerance dose levels.
作者: SHOCK    時間: 2025-3-24 20:26
Economic Recovery: Hope or Opportunity?,plication of cancer chemotherapy have introduced the concept of alternating non-cross-resistant agents applied intensively on a weekly basis. Another conceptual development has been the application of biochemical modulation utilizing a noncytotoxic enhancing agent in conjunction with a primary cytotoxic drug.
作者: Kidnap    時間: 2025-3-24 23:39
https://doi.org/10.1007/978-3-031-26786-4 overall field of chemical modifiers has been recently reviewed in detail (. 1988, 1989; . et al. 1988a, 1989a, b). This article will highlight some of the rationale for the clinical use of radiation and chemotherapy modifiers, with particular emphasis on the use of the hypoxic cell sensitizers as a continuous infusion.
作者: Texture    時間: 2025-3-25 06:34

作者: Amendment    時間: 2025-3-25 07:29

作者: interior    時間: 2025-3-25 13:09
Hypoxic Cell Sensitizers overall field of chemical modifiers has been recently reviewed in detail (. 1988, 1989; . et al. 1988a, 1989a, b). This article will highlight some of the rationale for the clinical use of radiation and chemotherapy modifiers, with particular emphasis on the use of the hypoxic cell sensitizers as a continuous infusion.
作者: OFF    時間: 2025-3-25 18:35

作者: exceed    時間: 2025-3-25 23:43

作者: 石墨    時間: 2025-3-26 02:14
Concomitant Continuous Infusion Chemotherapy and Radiation978-3-642-84186-6Series ISSN 0942-5373 Series E-ISSN 2197-4187
作者: 不可侵犯    時間: 2025-3-26 05:42
https://doi.org/10.1007/978-981-13-7685-6demonstrated the importance of dose intensity for optimal antineoplastic effect. The administration schedule required to achieve maximal dose intensity, however, is not the same for every drug. The pharmacodynamic response to any drug is a function of concentration and duration of exposure. The simp
作者: 同步信息    時間: 2025-3-26 11:09

作者: homocysteine    時間: 2025-3-26 15:36

作者: 維持    時間: 2025-3-26 17:51

作者: conjunctivitis    時間: 2025-3-26 21:49
Munich Studies on Innovation and Competitiondvances have been made, based on innovative concepts of applied anatomy and on an improved understanding of cell biology, but also based on pure technological progress at the mechanical level. In fact, continuous infusion of chemotherapy is just one of several techniques that reflect the level of mu
作者: corn732    時間: 2025-3-27 02:56
https://doi.org/10.1007/978-3-031-26786-4de the radiation sensitizers and protectors, which are theoretically of no therapeutic value by themselves but are clinically active only when used in conjunction with irradiation. Combined modality therapy using radiation therapy with the standard cytotoxic chemotherapeutic agents is the major focu
作者: 沐浴    時間: 2025-3-27 06:08

作者: rods366    時間: 2025-3-27 12:38

作者: 下垂    時間: 2025-3-27 16:29

作者: insert    時間: 2025-3-27 18:15
Effective Communication Strategies,ors tested. Y. and S. first reported that WR-2721 could increase the radiation resistance of murine skin and bone marrow by factors of 2.5 and 2.7, respectively, without increasing the radiation resistance of the animals’ solid mammary tumors. (Yuhas 1980a) Preclinical data on WR-2721 have been expa
作者: Decimate    時間: 2025-3-28 00:27

作者: Peculate    時間: 2025-3-28 03:21

作者: hidebound    時間: 2025-3-28 07:46
https://doi.org/10.1007/3-7908-1705-8h disease site (E. and A. 1988). The role of radiation therapy in the management of these diseases was not recognized until fairly recently; initially radiation therapy played a palliative role but was not regarded with favor as either a definitive or an adjunct modality. Early suboptimal equipment
作者: 移動    時間: 2025-3-28 13:47
https://doi.org/10.1007/3-7908-1705-8dvanced local disease but also the planning of early stage adjuvant therapy. W. and D. (1979), through a study of autopsy series, estimated that more than 80% of patients with metastatic colorectal cancer had tumor involvement of the liver. It was also estimated that in more than half of those dying
作者: 沙漠    時間: 2025-3-28 16:17
https://doi.org/10.1007/978-3-642-84186-6Tumor; brain; brain tumors; cancer; cancer treatment; carcinoma; cell; chemotherapy; clinical trial; metastas
作者: 全部逛商店    時間: 2025-3-28 20:23
978-3-642-84188-0Springer-Verlag Berlin Heidelberg 1991
作者: 載貨清單    時間: 2025-3-29 00:03
https://doi.org/10.1007/978-981-13-7685-6The last three decades have seen the development of chemotherapy from being a means of palliating cancer symptoms and occasionally prolonging survival times, to being a means of effecting a cure. However, even now, only 15% of patients with advanced cancer can be cured by the use of chemotherapy alone.
作者: Memorial    時間: 2025-3-29 03:24
Trade Routes to Sustained Economic GrowthDrug delivery by infusion is a promising avenue for improving the therapeutic index of several classes of drugs. Although the pharmacological rationale for infusional therapy has been long appreciated, relevant clinical trials have only recently begun to emerge, and only in a relatively few forms of cancer.
作者: AER    時間: 2025-3-29 07:29
The Development of Chemotherapy Drugs as Radiosensitizers: an OverviewThe last three decades have seen the development of chemotherapy from being a means of palliating cancer symptoms and occasionally prolonging survival times, to being a means of effecting a cure. However, even now, only 15% of patients with advanced cancer can be cured by the use of chemotherapy alone.
作者: 有抱負(fù)者    時間: 2025-3-29 14:25
Combination Chemotherapy by Infusion in Solid TumorsDrug delivery by infusion is a promising avenue for improving the therapeutic index of several classes of drugs. Although the pharmacological rationale for infusional therapy has been long appreciated, relevant clinical trials have only recently begun to emerge, and only in a relatively few forms of cancer.
作者: Amylase    時間: 2025-3-29 19:07
Concomitant Continuous Infusion Chemotherapy and Radiation
作者: 格言    時間: 2025-3-29 20:06

作者: 小隔間    時間: 2025-3-30 03:49

作者: oblique    時間: 2025-3-30 05:31

作者: 他日關(guān)稅重重    時間: 2025-3-30 11:31

作者: TOM    時間: 2025-3-30 13:41

作者: 急性    時間: 2025-3-30 20:04
Strategies for Overcoming Challenges,ally hypoxic cells thought to exist in many human tumors. A recent study examining the patterns of failure following radiation treatment for high grade brain tumors revealed that 78% of unifocal tumors recurred within 2 cm of the enhancing edge of the tumor, as demonstrated by the CT scan (W. et al.
作者: 建筑師    時間: 2025-3-30 21:59

作者: 牛的細(xì)微差別    時間: 2025-3-31 01:06

作者: 悶熱    時間: 2025-3-31 08:05
Textbook 1991fects resulting from the administration of commonly used drugs, such as 5-fluorouracil, cisplatinum and adriamycin, with concomitant radiation therapy. Much of the data has never before been published. The wealth of information in this volume makes it a valuable reference; at the same time it gives
作者: 秘密會議    時間: 2025-3-31 10:09
Experimental Rationale for Continuous Infusion Chemotherapydemonstrated the importance of dose intensity for optimal antineoplastic effect. The administration schedule required to achieve maximal dose intensity, however, is not the same for every drug. The pharmacodynamic response to any drug is a function of concentration and duration of exposure. The simp
作者: anatomical    時間: 2025-3-31 14:08
Combination Chemotherapy by Infusion in Hematological Malignanciesnt of hematological malignancies. For the past decade our group has been interested in the use of infusional chemotherapy in the treatment of lymphomas. The following discussion will review our experiences and those of others in this area. We will also comment on work by other investigators on the u
作者: 中國紀(jì)念碑    時間: 2025-3-31 20:58

作者: 空氣傳播    時間: 2025-4-1 00:31

作者: 逗留    時間: 2025-4-1 04:40
Advances in the Technology of Continuous Infusiondvances have been made, based on innovative concepts of applied anatomy and on an improved understanding of cell biology, but also based on pure technological progress at the mechanical level. In fact, continuous infusion of chemotherapy is just one of several techniques that reflect the level of mu
作者: Melanoma    時間: 2025-4-1 08:41





歡迎光臨 派博傳思國際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
邛崃市| 大新县| 台南市| 彰武县| 宁陕县| 右玉县| 辰溪县| 乐都县| 溧阳市| 安吉县| 怀集县| 石渠县| 高青县| 潜江市| 庆云县| 富源县| 绥阳县| 永川市| 永顺县| 沂水县| 新巴尔虎左旗| 平湖市| 灵石县| 华亭县| 富平县| 龙山县| 哈尔滨市| 永和县| 边坝县| 滁州市| 龙陵县| 大安市| 历史| 衡阳市| 军事| 和平县| 渭源县| 朝阳县| 通城县| 重庆市| 横山县|